InvestorsHub Logo
Followers 1004
Posts 43226
Boards Moderated 0
Alias Born 03/17/2014

Re: cash4 post# 70

Tuesday, 01/31/2023 10:14:25 AM

Tuesday, January 31, 2023 10:14:25 AM

Post# of 114
$CNTX:

very small float considering the significant institutional ownership.


this can fly to $5 with this massive development:

Context Therapeutics' Clinical Partner Stemline Therapeutics, a Subsidiary of Menarini Group Receives FDA Approval of ORSERDU(TM) (elacestrant) in ER+, HER2-, ESR1-mutated Breast Cancer
7:30 am ET January 31, 2023 (Globe Newswire)
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CNTX News